Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects multi-blockbuster ...

Hamlet Gasoyan, MD, discussed the implications of a multiple myeloma study’s findings and their potential impact on clinical ...

If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.

The department used its new system for determining whether a condition is service-connected to give affected veterans access ...

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.

A pensioner who feels the cold intensely as a result of her blood cancer says her husband is taking cold showers to slash ...

Age 18 years or older Relapsed or refractory multiple myeloma that was progressing Previously received at least three lines of cancer treatment: a proteasome inhibitor, an immune system modulator ...